The Molecular Basis for Perforin Oligomerization and Transmembrane Pore Assembly

Immunity

Volumn 30, Issue 5, 2009, Pages 684-695

  Baran, Katherine ^a   Dunstone, Michelle ^b   Chia, Jenny ^a   Ciccone, Annette ^a   Browne, Kylie A ^a   Clarke, Christopher J P ^a,c   Lukoyanova, Natalya ^d   Saibil, Helen ^d   Whisstock, James C ^b   Voskoboinik, Ilia ^a,c   Trapani, Joseph A ^a,b,c  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

MOLIMMUNO

Indexed keywords

ARGININE; GLUTAMINE; PERFORIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; APOPTOSIS; ARTICLE; BASOPHIL; CHANNEL GATING; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MOLECULAR INTERACTION; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN FOLDING; PROTEIN POLYMERIZATION; PROTEIN TARGETING; RAT; SITE DIRECTED MUTAGENESIS;

ANIMALS; APOPTOSIS; CELL LINE, TUMOR; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; CELLULAR STRUCTURES; COMPLEMENT C8; ERYTHROCYTES; GRANZYMES; HUMANS; JURKAT CELLS; MUTATION; PERFORIN; POROSITY; RATS; RECOMBINANT PROTEINS; SHEEP;

EID: 65549121526     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2009.03.016     Document Type: Article

References (50)

1. Bird C.H., Sun J., Ung K., Karambalis D., Whisstock J.C., Trapani J.A., and Bird P.I. Cationic sites on granzyme B contribute to cytotoxicity by promoting its uptake into target cells. Mol. Cell. Biol. 25 (2005) 7854-7867
2. Blumenthal R., Millard P.J., Henkart M.P., Reynolds C.W., and Henkart P.A. Liposomes as targets for granule cytolysin from cytotoxic large granular lymphocyte tumors. Proc. Natl. Acad. Sci. USA 81 (1984) 5551-5555
3. Bolitho P., Voskoboinik I., Trapani J.A., and Smyth M.J. Apoptosis induced by the lymphocyte effector molecule perforin. Curr. Opin. Immunol. 19 (2007) 339-347
4. Clementi R., Locatelli F., Dupre L., Garaventa A., Emmi L., Bregni M., Cefalo G., Moretta A., Danesino C., Comis M., et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene. Blood 105 (2005) 4424-4428
5. Dang T.X., Hotze E.M., Rouiller I., Tweten R.K., and Wilson-Kubalek E.M. Prepore to pore transition of a cholesterol-dependent cytolysin visualized by electron microscopy. J. Struct. Biol. 150 (2005) 100-108
6. Dennert G., and Podack E.R. Cytolysis by H-2-specific T killer cells. Assembly of tubular complexes on target membranes. J. Exp. Med. 157 (1983) 1483-1495
7. Eswar N., Eramian D., Webb B., Shen M.Y., and Sali A. Protein structure modeling with MODELLER. Methods Mol. Biol. 426 (2008) 145-159
8. Froelich C.J., Orth K., Turbov J., Seth P., Gottlieb R., Babior B., Shah G.M., Bleackley R.C., Dixit V.M., and Hanna W. New paradigm for lymphocyte granule-mediated cytotoxicity. Target cells bind and internalize granzyme B, but an endosomolytic agent is necessary for cytosolic delivery and subsequent apoptosis. J. Biol. Chem. 271 (1996) 29073-29079
9. Hadders M.A., Beringer D.X., and Gros P. Structure of C8alpha-MACPF reveals mechanism of membrane attack in complement immune defense. Science 317 (2007) 1552-1554
10. Ishii E., Ueda I., Shirakawa R., Yamamoto K., Horiuchi H., Ohga S., Furuno K., Morimoto A., Imayoshi M., Ogata Y., et al. Genetic subtypes of familial hemophagocytic lymphohistiocytosis: correlations with clinical features and cytotoxic T lymphocyte/natural killer cell functions. Blood 105 (2005) 3442-3448
11. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K.J., Podack E.R., Zinkernagel R.M., and Hengartner H. Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369 (1994) 31-37
12. Kagi D., Odermatt B., Seiler P., Zinkernagel R.M., Mak T.W., and Hengartner H. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice. J. Exp. Med. 186 (1997) 989-997
13. Konagurthu A.S., Whisstock J.C., Stuckey P.J., and Lesk A.M. MUSTANG: A multiple structural alignment algorithm. Proteins 64 (2006) 559-574
14. Kwon B.S., Wakulchik M., Liu C.C., Persechini P.M., Trapani J.A., Haq A.K., Kim Y., and Young J.D. The structure of the mouse lymphocyte pore-forming protein perforin. Biochem. Biophys. Res. Commun. 158 (1989) 1-10
15. Larkin M.A., Blackshields G., Brown N.P., Chenna R., McGettigan P.A., McWilliam H., Valentin F., Wallace I.M., Wilm A., Lopez R., et al. Clustal W and Clustal X version 2.0. Bioinformatics 23 (2007) 2947-2948
16. Lichtenheld M.G., Olsen K.J., Lu P., Lowrey D.M., Hameed A., Hengartner H., and Podack E.R. Structure and function of human perforin. Nature 335 (1988) 448-451
17. MacDonald R.C., MacDonald R.I., Menco B.P., Takeshita K., Subbarao N.K., and Hu L.R. Small-volume extrusion apparatus for preparation of large, unilamellar vesicles. Biochim. Biophys. Acta 1061 (1991) 297-303
18. Masson D., and Tschopp J. Isolation of a lytic, pore-forming protein (perforin) from cytolytic T-lymphocytes. J. Biol. Chem. 260 (1985) 9069-9072
19. Mehta P.A., Davies S.M., Kumar A., Devidas M., Lee S., Zamzow T., Elliott J., Villanueva J., Pullen J., Zewge Y., and Filipovich A. Perforin polymorphism A91V and susceptibility to B-precursor childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group. Leukemia 20 (2006) 1539-1541
20. Molleran Lee S., Villanueva J., Sumegi J., Zhang K., Kogawa K., Davis J., and Filipovich A.H. Characterisation of diverse PRF1 mutations leading to decreased natural killer cell activity in North American families with haemophagocytic lymphohistiocytosis. J. Med. Genet. 41 (2004) 137-144
21. Myers M.A., Davies J.M., Tong J.C., Whisstock J., Scealy M., Mackay I.R., and Rowley M.J. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J. Immunol. 165 (2000) 3830-3838
22. Nakajima H., Park H.L., and Henkart P.A. Synergistic roles of granzymes A and B in mediating target cell death by rat basophilic leukemia mast cell tumors also expressing cytolysin/perforin. J. Exp. Med. 181 (1995) 1037-1046
23. Peitsch M.C., Amiguet P., Guy R., Brunner J., Maizel Jr. J.V., and Tschopp J. Localization and molecular modelling of the membrane-inserted domain of the ninth component of human complement and perforin. Mol. Immunol. 27 (1990) 589-602
24. Persechini P.M., Ojcius D.M., Adeodato S.C., Notaroberto P.C., Daniel C.B., and Young J.D. Channel-forming activity of the perforin N-terminus and a putative α-helical region homologous with complement C9. Biochemistry 31 (1992) 5017-5021
25. Podack E.R., and Dennert G. Assembly of two types of tubules with putative cytolytic function by cloned natural killer cells. Nature 302 (1983) 442-445
26. Podack E.R., and Tschopp J. Circular polymerization of the ninth component of complement. Ring closure of the tubular complex confers resistance to detergent dissociation and to proteolytic degradation. J. Biol. Chem. 257 (1982) 15204-15212
27. Podack E.R., Young J.D., and Cohn Z.A. Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules. Proc. Natl. Acad. Sci. USA 82 (1985) 8629-8633
28. Rosado C.J., Buckle A.M., Law R.H., Butcher R.E., Kan W.T., Bird C.H., Ung K., Browne K.A., Baran K., Bashtannyk-Puhalovich T.A., et al. A common fold mediates vertebrate defense and bacterial attack. Science 317 (2007) 1548-1551
29. Rosado C.J., Kondos S., Bull T.E., Kuiper M.J., Law R.H.P., Buckle A.M., Voskoboinik I., Bird P.I., Trapani J.A., Whisstock J.C., and Dunstone M.A. The MACPF/CDC family of pore forming toxins. Cell. Microbiol. 10 (2008) 1765-1774
30. Rossjohn J., Feil S.C., McKinstry W.J., Tweten R.K., and Parker M.W. Structure of a cholesterol-binding, thiol-activated cytolysin and a model of its membrane form. Cell 89 (1997) 685-692
31. Shi L., Mai S., Israels S., Browne K., Trapani J.A., and Greenberg A.H. Granzyme B (GraB) autonomously crosses the cell membrane and perforin initiates apoptosis and GraB nuclear localization. J. Exp. Med. 185 (1997) 855-866
32. Shinkai Y., Takio K., and Okumura K. Homology of perforin to the ninth component of complement (C9). Nature 334 (1988) 525-527
33. Shiver J.W., and Henkart P.A. A noncytotoxic mast cell tumor line exhibits potent IgE-dependent cytotoxicity after transfection with the cytolysin/perforin gene. Cell 64 (1991) 1175-1181
34. Slade D.J., Lovelace L.L., Chruszcz M., Minor W., Lebioda L., and Sodetz J.M. Crystal structure of the MACPF domain of human complement protein C8 alpha in complex with the C8 gamma subunit. J. Mol. Biol. 379 (2008) 331-342
35. Stepp S.E., Dufourcq-Lagelouse R., Le Deist F., Bhawan S., Certain S., Mathew P.A., Henter J.I., Bennett M., Fischer A., de Saint Basile G., and Kumar V. Perforin gene defects in familial hemophagocytic lymphohistiocytosis. Science 286 (1999) 1957-1959
36. Stinchcombe J.C., and Griffiths G.M. Secretory mechanisms in cell-mediated cytotoxicity. Annu. Rev. Cell Dev. Biol. 23 (2007) 495-517
37. Sutton V.R., Waterhouse N.J., Baran K., Browne K., Voskoboinik I., and Trapani J.A. Measuring cell death mediated by cytotoxic lymphocytes or their granule effector molecules. Methods 44 (2008) 241-249
38. Tilley S.J., Orlova E.V., Gilbert R.J., Andrew P.W., and Saibil H.R. Structural basis of pore formation by the bacterial toxin pneumolysin. Cell 121 (2005) 247-256
39. Trapani J.A. Dual mechanisms of apoptosis induction by cytotoxic lymphocytes. Int. Rev. Cytol. 182 (1998) 111-192
40. Trapani J.A., Sutton V.R., Thia K.Y., Li Y.Q., Froelich C.J., Jans D.A., Sandrin M.S., and Browne K.A. A clathrin/dynamin- and mannose-6-phosphate receptor-independent pathway for granzyme B-induced cell death. J. Cell Biol. 160 (2003) 223-233
41. Tschopp J., Masson D., and Stanley K.K. Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis. Nature 322 (1986) 831-834
42. Uellner R., Zvelebil M.J., Hopkins J., Jones J., MacDougall L.K., Morgan B.P., Podack E., Waterfield M.D., and Griffiths G.M. Perforin is activated by a proteolytic cleavage during biosynthesis which reveals a phospholipid-binding C2 domain. EMBO J. 16 (1997) 7287-7296
43. Voskoboinik I., Thia M.C., De Bono A., Browne K., Cretney E., Jackson J.T., Darcy P.K., Jane S.M., Smyth M.J., and Trapani J.A. The functional basis for hemophagocytic lymphohistiocytosis in a patient with co-inherited missense mutations in the perforin (PFN1) gene. J. Exp. Med. 200 (2004) 811-816
44. Voskoboinik I., Thia M.C., Fletcher J., Ciccone A., Browne K., Smyth M.J., and Trapani J.A. Calcium-dependent plasma membrane binding and cell lysis by perforin are mediated through its C2 domain: A critical role for aspartate residues 429, 435, 483, and 485 but not 491. J. Biol. Chem. 280 (2005) 8426-8434
45. Voskoboinik I., Thia M.C., and Trapani J.A. A functional analysis of the putative polymorphisms A91V and N252S and 22 missense perforin mutations associated with familial hemophagocytic lymphohistiocytosis. Blood 105 (2005) 4700-4706
46. Voskoboinik I., Smyth M.J., and Trapani J.A. Perforin-mediated target-cell death and immune homeostasis. Nat. Rev. Immunol. 6 (2006) 940-952
47. Voskoboinik I., Sutton V.R., Ciccone A., House C.M., Chia J., Darcy P.K., Yagita H., and Trapani J.A. Perforin activity and immune homeostasis: The common A91V polymorphism in perforin results in both presynaptic and postsynaptic defects in function. Blood 110 (2007) 1184-1190
48. Whisstock J., Lesk A.M., and Carrell R. Modeling of serpin-protease complexes: antithrombin-thrombin, alpha 1-antitrypsin (358Met→Arg)-thrombin, alpha 1-antitrypsin (358Met→Arg)-trypsin, and antitrypsin-elastase. Proteins 26 (1996) 288-303
49. Young J.D., Cohn Z.A., and Podack E.R. The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities. Science 233 (1986) 184-190
50. Young J.D., Podack E.R., and Cohn Z.A. Properties of a purified pore-forming protein (perforin 1) isolated from H-2-restricted cytotoxic T cell granules. J. Exp. Med. 164 (1986) 144-155